comparemela.com
Home
Live Updates
Urrent Ards Us0403341045 - Breaking News
Pages:
Latest Breaking News On - Urrent ards us0403341045 - Page 1 : comparemela.com
Aridis Pharmaceuticals : Termination of Material Agreement - Form 8-K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT . | March 29, 2023
United states
Los gatos
Vu truong
Aridis pharmaceuticals inc
Securities exchange
Medimmune limited
Exchange act
Securities act
Securities exchange act
Material definitive
Aridis pharmaceuticals
License agreement
Upfront cash payment
Nc stock exchange
Press release
Urrent ards us0403341045
vimarsana © 2020. All Rights Reserved.